AbbVie Inc. products

(adalimumab) injection, for subcutaneous use

(upadacitinib) extended-release tablets for oral use

(risankizumab-rzaa) injection, for subcutaneous use

(onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use

(citalopram hydrobromide) tablets

(divalproex sodium) delayed-release tablets, for oral use

(divalproex sodium) extended-release tablets, for oral use

(divalproex sodium) delayed release capsules, for oral use

(carbidopa and levodopa) enteral suspension

(levomilnacipran) extended-release capsules, for oral use